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Facial morphogenesis requires a series of precisely orchestrated molecular events to
promote the growth and fusion of the facial prominences. Cleft palate (CP) results from
perturbations in this process. The transcriptional repressor Msx1 is a key participant
in these molecular events, as demonstrated by the palatal clefting phenotype observed
in Msx1−/− embryos. Here, we exploited the high degree of conservation that exists in
the gene regulatory networks that shape the faces of birds and mice, to gain a deeper
understanding of Msx1 function in CP. Histomorphometric analyses indicated that facial
development was disrupted as early as E12.5 in Msx1−/− embryos, long before the
palatal shelves have formed. By mapping the expression domain of Msx1 in E11.5 and
E12.5 embryos, we found the structures most affected by loss of Msx1 function were the
maxillary prominences. Maxillary growth retardation was accompanied by perturbations
in angiogenesis that preceded the CP phenotype. Experimental chick manipulations and
in vitro assays showed that the regulation of Msx1 expression by the Wnt/β-catenin
pathway is highly specific. Our data in mice and chicks indicate a conserved role for Msx1
in regulating the outgrowth of the maxillary prominences, and underscore how imbalances
in Msx1 function can lead of growth disruptions that manifest as CP.
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INTRODUCTION
Mid-facial morphogenesis involves the choreographed growth of
the facial prominences with each other and with other regions of
the growing head. When this highly synchronized process is dis-
rupted, by either genetic or environmental influences, the result
is cleft lip, cleft palate (CP), and the combination [CL/P; (Dixon
et al., 2011)].
Avian and mammalian models have been used to study the
molecular and cellular basis for CP and CL/P because during early
embryonic development the faces of chicks, mice, and humans
are remarkably similar (Helms and Schneider, 2003; Brugmann
and Moody, 2005; Juriloff et al., 2005; Juriloff and Harris, 2008).
Only during later stages of fetal development do species-specific
facial characteristics emerge (Brugmann et al., 2006). This con-
servation in facial morphology is paralleled by an equally robust
conservation in the gene regulatory networks that shape the
face (Brugmann and Moody, 2005; Juriloff and Harris, 2008).
Mouse models have an advantage in that like humans, slight
variations in facial morphology can cause facial clefting (Juriloff
et al., 2005, 2006; Juriloff and Harris, 2008). The disadvantage is
that predisposing variations in facial form are difficult to detect
(Boughner and Hallgrimsson, 2008; Boughner et al., 2008). Birds
have much greater diversity in facial form, most noticeable when
comparing different orders [i.e., ducks vs. quails (Helms and
Schneider, 2003; Schneider and Helms, 2003)] but inter-species
crosses are impossible. When used in combination, genetic mod-
els and experimental manipulations can provide useful insights
into the molecular regulation of facial form.
We were interested in understanding more about the con-
sequence of Msx1 deletion on facial development. Msx1 is a
homeobox gene encoding transcriptional repressor and it func-
tions in a variety of cell types to control processes as varied
as proliferation, differentiation and angiogenesis (Marazzi et al.,
1997; Odelberg et al., 2000; Hu et al., 2001; Han et al., 2003; Ishii
et al., 2005; Lopes et al., 2011). The phenotype resulting from
deletion of Msx1 clearly demonstrates the critical role for this
transcription factor plays in craniofacial development: Msx1−/−
mouse embryos have complete secondary CP, as well as tooth age-
nesis (Satokata and Maas, 1994). In humans, mutations in MSX1
are among the genes implicated in CLP and CP (Lidral et al.,
1998; Jezewski et al., 2003; Vieira et al., 2003; Suzuki et al., 2004;
Tongkobpetch et al., 2006; Suazo et al., 2010; Salahshourifar et al.,
2011).
Here, we made use of both mouse genetic models and avian
approaches to gain a deeper appreciation of the role of Msx1
in facial development and facial clefting. Morphologic analy-
ses of mice carrying null mutations in Msx1 revealed critical,
early stages of prominence growth that were disrupted by loss
of Msx1. Experimental manipulations in chick embryos under-
scored the critical importance of proper levels of Msx1 function
www.frontiersin.org September 2012 | Volume 3 | Article 375 | 1
Medio et al. Wnt and Msx1 in facial development
for maxillary growth, and also highlighted the specific regulation
of Msx1 by the Wnt/β-catenin pathway.
MATERIALS ANDMETHODS
GENERATION AND GENOTYPING OF Msx1 EMBRYOS
All animal experiments were done in accordance with the
Stanford University institutional guidelines. The Msx1 null allele
was generated by the insertion of a n-LacZ insert in the second
exon of mouse Msx1 gene (Houzelstein et al., 1997). Genotypes
were confirmed by PCR using previously described primers and
conditions (Houzelstein et al., 1997).
MANIPULATION OF CHICK EMBRYOS
Fertilized chicken eggs (Gallus gallus, Rhode Island Red Chickens
from Petaluma Farms, Petaluma, CA) were prepared for surgical
manipulations bymaking a small hole in the shell directly over the
embryo. The replication competent retrovirus (RCAS) encoding
Wnt2b (Cho and Cepko, 2006) was injected into the frontonasal
prominence at St. 18. RCAS vectors are genetically programmed
to infect cells and to integrate their genomes stably into host cells’
DNA (Bell and Brickell, 1997); therefore, electroporation is not
required.
COLLECTION AND PREPARATION OF EMBRYOS
Mouse and chick embryos were collected in 4◦C PBS then fixed
in 4% paraformaldehyde (PFA) overnight at 4◦C, dehydrated
through an ethanol series and stored in 100% ethanol. Most
tissues were embedded in paraffin and cut at 8μm using a stan-
dard microtome. For each mouse stage we used an average of
7 embryos from the same litter, and embryos were collected at
E12.5, E13.5, and E15.5. Chick embryos were collected at St.
17HH, 20HH, and 25HH.
ETHIDIUM BROMIDE STAINING AND HISTOMORPHOMETRY
Mouse heads were incubated in 1xPBS containing ethidium bro-
mide for 10min and imaged in a 2× magnification using a
dissecting microscope (Leica) under UV light. EtBr intercalates
into DNA in cells of the epidermis and the resulting images, which
are converted to grayscale (Figures 1, 2) clearly show surface
topography.
Morphometric measurements were obtained from the EtBr
images using the Adobe Photoshop “ruler” tool. Maxillary length:
the largest distance between the nasal tip and the most proxi-
mal point of the maxilla from a lateral view; Maxillary width: the
widest distance between the two extremes of the maxillary promi-
nence from a frontal view; Internasal pit distance: the farthest
distance between the nasal pit from a frontal view.
The measurements are expressed by mean and standard devia-
tion, and the groups were compared by unpaired Student’s t-test.
A value p < 0.05 was considered statistically significant.
IMMUNOHISTOCHEMISTRY
For all antibody staining, de-paraffinized tissue sections were
immersed in cold acetone and treated with 0.1% TritonX-100.
Sections were incubated overnight at 4◦C with a 1:1000 dilu-
tion of incubation in monoclonal anti-PECAM and anti-Col4a1
(Sigma, St. Louis, MO, USA) 1% donkey IgG overnight, and
incubated for 1 h at room temperature in a 1:1000 dilution
FIGURE 1 | Loss of Msx1 causes facial dysmorphologies in E15.5
mouse embryos. (A and B) Ventral view of Msx1+/− and Msx1−/−
embryos showing the primary (1) and secondary (2) palates. Dashed lines
indicate the edges of the maxillary prominence. (C and D) Dorsal view of
Msx1+/− and Msx1−/− embryos. Arrow points to abnormal organization of
fiber tracts in the sub-commissural organ. (E and F) A higher magnification
of Msx1+/− and Msx1−/− embryos; dashed lines indicates width of the
rostrum (Maxillary width in Table 1). Dashed arrows indicate the length of
the rostrum (maxillary length in Table 1). (G and H) Lateral view of
Msx1+/− and Msx1−/− embryos. Dashed lines indicate outline of the
maxillary prominence; dashed arrows indicate length of the rostrum.
Mx, Maxillary.
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FIGURE 2 | Facial dysmorphologies in Msx1−/−embryos are detectable
at E13.5 but not at E12.5. (A and B) Frontal view of E13.5 Msx1+/− and
Msx1−/− embryos. Dashed lines indicate edges of the maxillary
prominence and dashed arrows, distance between the nasal pits (internasal
pit distance in Table 1). (C and D) Lateral view of Msx1+/− and Msx1−/−
embryos. Dashed lines demarcate outline of the maxillary prominence;
dashed arrow indicate length of the rostrum (maxillary length in Table 1).
(E and F) Dorsal view of Msx1+/− and Msx1−/− embryos; bracket indicates
size of the frontonasal prominence. Dashed arrows indicates width of the
diencephalon. (G and H) Frontal view of E12.5 Msx1+/− and Msx1−/−
embryos. (I and J) Lateral view, where dashed lines demarcates outline of
the maxillary prominence. (K and L) Ventral view. di, diencephalon; fn,
frontonasal prominence; mn, mandibular prominence; mx, maxillary
prominence; np, nasal pit; te, telencephalon.
of FITC conjugated anti-mouse secondary antibody (Jackson
Immunoresearch) in 1% donkey IgG. Slides were washed in 1:10
000 dilution of Hoechst in PBS. Image analysis of positive staining
pixels was performed using Adobe Photoshop “color range” tool.
In situ HYBRIDIZATION
Templates for the relevant mRNAs [mouse and chick Msx1, gag
(Wang et al., 2004), Wnt2b, Shh, Fgf8, Pax6 (Abzhanov et al.,
2007)] were amplified from embryonic mouse cDNA by PCR
using sequence-specific primers that included the promoter sites
for T3 or T7 RNA polymerase. Antisense riboprobe for each gene
was transcribed with either T3 or T7 RNA polymerase in the
presence of Dig-11-UTP (mouse embryos; Roche; Indianapolis,
IN, USA) or 35S-labeled riboprobes (chick embryos) (Albrecht
et al., 1997). Hybridizations and washes were performed at high
stringency as described in detail elsewhere (Albrecht et al., 1997).
Images of radioactive in situ hybridization assays are pseudo-
colored superimpositions of the in situ hybridization signal and
a blue nuclear stain (Hoescht Stain, Sigma) that are made using
Adobe Photoshop. Briefly, two separate images were captured
in Adobe Photoshop. One image was a fluorescent image of
the nuclei, and the other was a dark field image of the in situ
hybridization signal. These images are superimposed as differ-
ent layers within Photoshop. The “colorize” tool is used to add a
contrasting color to the in situ hybridization layer. No changes in
threshold intensities are made; however, slight adjustments to the
contrast and brightness were performed to accurately reflect what
is observed with the microscope. The images are then flattened for
importation into Adobe Illustrator, where the final figures were
assembled.
MOUSE EMBRYONIC FIBROBLAST (MEF) TREATMENT WITH Wnt
LIGANDS
Wild-type mouse embryos (n = 3) were harvested at stage
E11.5. Their limb buds were mechanically disrupted with a
pipette and they were cultured in 25 cm2 flasks for 48 h in
DMEM-High Glucose (Gibco) supplemented with 10% fetal
bovine serum (Gibco) and 1% penicillin/streptomycin (Gibco).
Once attached, cells were passaged into 6-well plates, 3 wells
per condition. The same volume of either phosphate buffered
saline, Wnt3a (0.2 ng/ml; R&D Systems) or Wnt5a (0.2 ng/ml;
R&D Systems) was added into each well. After 4 h, RNA was
extracted with RNeasy mini kit (Qiagen). cDNA was pre-
pared from 1μg of each RNA sample with SuperScript III kit
(Invitrogen). Quantitative real time PCR for Msx1 (Forward
primer: ATGCTCTGGTGAAGGCCGAAAG; reverse primer:
TTGCGGTTGGTCTTGTGCTTGC) and Gapdh (Forward
primer: CATGGCCTTCCGTGTTCCTA, reverse primer:
GCGGCACGTCAGATCCA) was performed with Sybr Green
mix in ABI 7900HT system (Applied Biosystems).
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RESULTS
CRANIOFACIAL ABNORMALITIES AND CLEFT PALATE IN
Msx1−/− MOUSE DEVELOPMENT
Analyses of E15.5 Msx1−/− embryos confirmed the previ-
ously described phenotype of clefting in the secondary palate
[Figures 1A,B and see (Satokata and Maas, 1994; Hu et al., 2001;
Zhang et al., 2002; Levi et al., 2006)]. We also observed the abnor-
mal organization of fiber tracts in the sub-commissural organ
(Figures 1C,D) as described previously (Bach et al., 2003; Ramos
et al., 2004).
Msx1−/− embryos are described as having a “deficiency in
both mandibular and maxillary development” (Satokata and
Maas, 1994); we focused on this aspect of craniofacial devel-
opment. E15.5, Msx1−/− embryos have a rostrum that is 28%
shorter along the coronal plane (p = 0.002) but not appreciably
wider along the sagittal plane (p = 0.09, Table 1; Figures 1E,F).
From a dorsal perspective, this foreshortening of the rostrum
led to the appearance of more whisker primordia in Msx1−/−
embryos. From a lateral perspective, however, it was evident
that the number of whisker primordia was equivalent but their
distribution was changed: Msx1−/− embryos had more tightly
packed whisker primordia compared to heterozygous littermates
(Figures 1G,H). Msx1−/− embryos did, however, have fewer hair
follicle primordia covering the lateral sides of their developing
faces (Figures 1G,H).
In order to see when these facial alterations are first
observed, we collected embryos at progressively earlier stages and
undertook similar anatomical comparisons between homozy-
gous embryos and their heterozygous or wild-type littermates
(Table 1). At E13.5, Msx1−/− embryos had a wider mid-face, as
shown by the 37% increase in the distance between the nasal
pits (p < 0.0001, Table 1; Figures 2A,B). The Msx1−/− maxil-
lary prominences were shorter in the transverse plane (dotted
white line) and because of this the nasal cavity was visible from a
frontal view (Figures 2A,B). From a lateral perspective, Msx1−/−
embryos also displayed a 55% shortened rostrum in keeping
with the phenotype of E15.5 embryos (p < 0.0001, Table 1;
Figures 2C,D). From a superior or dorsal perspective, the fore-
shortened rostrum was clearly evident (brackets; Figures 2E,F).
The telencephalic vesicles of the Msx1−/− embryos were also
reduced along the coronal plane and the diencephalon was wider
in the sagittal plane (Figures 2E,F) in accordance with the role of
Msx1 in patterning the midbrain (Bach et al., 2003; Ramos et al.,
2004).
At E12.5, frontonasal, maxillary, andmandibular prominences
ofMsx1−/− embryos appeared equivalent in size, shape, and posi-
tion relative to littermate controls (Table 1; Figures 2G,H). From
a lateral perspective, a very slight, but not significant shortening of
the maxillary prominences was observed in the mutant (Table 1;
Figures 2I,J). From an inferior or ventral perspective, this subtle
difference was not apparent (Figures 2K,L).
From these histomorphometric analyses we conclude that the
developmental events leading to the CP observed in Msx1−/−
embryos are initiated between E12.5 and E13.5. This conclusion
is in contrast to other studies that have attributed the Msx1−/−
clefting phenotype to a failure of the palatal shelves to grow and to
fuse (Hu et al., 2001; Zhang et al., 2002; Levi et al., 2006). Our data
suggest that earlier developmental events contribute to the facial
clefting defect, although we cannot rule out that a compounded
phenomenon between maxillary prominence and palatal shelves
growth failure might be causing CP. Our next analyses focused on
identifying these Msx1-dependent developmental events.
EVALUATING Msx1 EXPRESSION IN CRANIOFACIAL DEVELOPMENT
In order to understand, which developmental events might be
altered in Msx1−/− embryos between E12.5 to E13.5, we eval-
uated Msx1 gene expression in the developing face [see also
(Mackenzie et al., 1991; Satokata and Maas, 1994; Zhang et al.,
2002; Levi et al., 2006)]. At E11.5, in situ hybridization analyses in
wild-type embryos showed expression of Msx1 in the maxillary,
lateral nasal, and mandibular prominences, as well as the sec-
ond pharyngeal arch and otic capsule region (Figure 3A). From
a frontal view, Msx1 was expressed in the maxillary, lateral nasal,
and fusing portions of the mandibular prominences but was
conspicuously absent from the frontonasal midline (Figure 3B).
From a superior view, Msx1 was expressed in the midline of the
developing cranial vault (Figure 3C). Note, however, that this
mesenchymal expression domain precedes any ossification of the
skull bones by almost 3.5 embryonic days.
At E12.5, the expression domain of Msx1 was more restricted
to growing edges of the maxillary and mandibular prominences
(Figures 3D,E). As observed at earlier stages, Msx1 transcripts are
Table 1 | Histomorphometric comparison of the heads from Msx1+/− and Msx1−/− embryos (E12.5, E13.5, and E15.5).
Measurement Embryo stage Length ± st.dev. (mm) p-value (unpaired t-test)
Msx1+/− Msx1−/−
Maxillary length E15.5 19.0 ± 1.8 (n = 7) 14.8 ± 1.1 (n = 5) 0.002*
Maxillary width E15.5 34.2 ± 3.4 (n = 7) 30.8 ± 2.9 (n = 5) 0.09 (n.s.)
Internasal pit distance E13.5 5.6 ± 0.4 (n = 11) 7.7 ± 0.5 (n = 7) <0.0001*
Maxillary length E13.5 8.1 ± 0.7 (n = 11) 5.2 ± 0.5 (n = 7) <0.0001*
Internasal pit distance E12.5 7.5 ± 0.8 (n = 4) 8.2 ± 0.5 (n = 5) 0.2 (n.s.)
Fiducials used to make the measurements are shown in Figures 1, 2.
Maxillary length, the largest distance between the nasal tip and the most proximal point of the maxilla from a lateral view; Maxillary width, the widest distance
between the two extremes of the maxillary prominence from a frontal view; Internasal pit distance, the farthest distance between the nasal pit from a frontal view.
*p < 0.05.
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FIGURE 3 | In situ hybridization forMsx1 at E11.5, E12.5 and E15.5 in the
developing face. (A) Lateral view of an E11.5 embryo shows Msx1
expression in the maxillary, mandibular, and lateral nasal prominences and in
the dorsal portion of the midbrain. (B) Frontal view illustrating that the midline
of frontonasal prominence (dashed lines) lacks Msx1. (C) Dorsal view
showing Msx1 expression in the midline of the midbrain. (D) Lateral view
at E12.5; Msx1 transcripts are detectable in the maxillary and mandibular
prominences. (E) Frontal view of the developing snout in an E12.5 embryo.
The midline of frontonasal prominence (dashed lines) lacks Msx1 expression.
(F) Coronal section of an E15.5 embryo. Msx1 is expressed in the epithelium
of the maxillary and mandibular prominences. fn, frontonasal prominence; ln,
lateral nasal prominence; m, medial nasal prominence; mb, midbrain; mn,
mandibular prominence; mx, maxillary prominence; np, nasal pit; te,
telencephalon.
less abundant in the frontonasal midline (dotted lines, Figure 3E).
At E15.5, Msx1 was primarily expressed in the whisker primordia
and in the epithelium of the maxillary and mandibular promi-
nences (Figure 3F). From these molecular analyses we concluded
that the sites most likely affected by loss of Msx1 function were
the maxillary, median and lateral nasal prominences. Given the
continued expression of Msx1 in the growing edges of the max-
illae, and the phenotypes of Msx1−/− embryos, we focused our
attention on this prominence and its derivatives.
Msx1 REGULATES ANGIOGENESIS IN THE DEVELOPING FACE
In order to understand how ablation of Msx1 expression affected
growth of the maxillary prominences, we prepared matching tis-
sue sections from control Msx1+/− and Msx1−/− embryos and
monitored how vascularization was affected by loss of Msx1.
Using platelet endothelial cell adhesion molecule (PECAM) to
identify endothelial cells (Albelda et al., 1991) we first evalu-
ated embryos for changes in the pattern of angiogenesis. Our
reasoning was that the foreshortened maxillary prominences in
the Msx1−/− embryos might result from a lack of oxygen and
nutrients delivered via the bloodstream. In E12.5 Msx1+/− con-
trols, PECAM immunostaining of blood vessels was broadly dis-
tributed throughout the maxillary and frontonasal mesenchyme
(Figures 4A,C). Image analyses of Msx1+/− embryos revealed
that 0.9% of the pixels in the maxillary prominence were pos-
itive for PECAM staining (Figures 4E,G). We also noted that
the lumen of the vessels was uniformly small (Figures 4E,G).
We observed a similar distribution of blood vessels in Msx1−/−
embryos (Figures 4B,D) with one notable exception: the lumens
of the vessels were on average much larger (Figures 4F,H), which
altered their density. Using image analyses we found that in
Msx1−/− embryos only 0.3% of the pixels in the same region were
PECAM positive (compare Figures 4E,F).
To confirm the vascular phenotype in Msx1−/− embryos, we
made use of Type IV collagen immunostaining to identify peri-
cytes that surround mature blood vessels (Jeon et al., 1996). In
E15.5 Msx1+/− embryos, ColIV staining was evident through-
out the facial mesenchyme and nasal septum (Figures 4I,K),
with a stronger staining near the nasal cartilage and between
the nasal cartilage and the nasal ectoderm (Figures 4M,O). In
Msx1−/− embryos there was a clear enrichment in pericytes-
covered blood vessels next to the nasal cartilage and nasal
ectoderm (Figures 4J,L). Image analyses indicated there was a
1.3-fold enrichment in ColIV staining in Msx1−/− embryos
(Figures 4N,P), suggesting that the earlier vascular defect had
undergone a rebound, resulting in a greater density of blood
vessels in the E15.5 Msx1−/− face.
Msx1 IS REGULATED BY Wnt/β-CATENIN SIGNALING
Msx1 orthologs are found in a variety of species, from C. ele-
gans to vertebrates including Gallus gallus, Mus musculus, and
Homo sapiens. Given the highly conserved nature of the DNA
sequence we wondered if the pattern of gene expression, and
thus perhaps the function of Msx1, was conserved among these
species. We chose an avian model because of the ease with
which embryos can be manipulated, collected, and evaluated
[Figures 5A,B; and see Brugmann et al. (2010)]. At stage 17HH,
Msx1 was strongly expressed in the medial and lateral edges of the
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FIGURE 4 | Loss ofMsx1 leads to abnormal angiogenesis. Immunostaining
for the endothelial marker PECAM in coronal sections of E12.5 (A,C,E,G)
Msx1+/− and (B,D,F,H) Msx1−/− embryos in increasing magnifications: 2.5×
(A,B), 5× (C,D), detailed frontonasal prominence at 10× (E,F), and detailed
maxillary prominence at 10× (G,H). Immunostaining for the pericyte marker
Type IV collagen in coronal sections of E15.5 (I,K,M,O)Msx1+/− and (J,L,N,P)
Msx1−/− embryos in increasing magnifications: 5× (I,J), 10× (K,L), detailed
nasal septum at 20× (M,N), and detailed nasal cartilage at 20× (O,P). e, eye;
fn, frontonasal prominence; mes, mesenchyme; mx, maxillary prominence;
nc, nasal cartilage; ne, nasal ectoderm; s, nasal septum.
nasal pits, throughout the maxillary prominences and in the distal
and proximal edges of the mandibular prominences (Figure 5A).
At stage 25HH, Msx1 expression was observed mainly in the
mandibular and maxillary prominences (Figure 5B). It was also
expressed in the lateral nasal and medial nasal prominences, but
was excluded from themidline (frontonasal) portion (Figure 5B).
These expression domains are highly reminescent to those in the
developing mouse face (Figure 3).
Others (Song et al., 2009) and we hypothesize that Wnt/β-
catenin signaling regulates Msx1 transcription. To test this the-
ory we over-expressed a Wnt ligand in the developing facial
prominences of chick embryos and then assessed how this over-
activation of the Wnt pathway affected Msx1 expression. Chicken
embryos at stage 18HH were injected with RCAS:Wnt2b (Cho
et al., 2006). We evaluated morphology (Figure 5C), and endoge-
nous pattern of Wnt2b and found transcripts in the frontonasal
ectoderm and in the mandibular ectoderm (Figure 5D).
Twenty-four hours after delivery of RCAS:Wnt2b, we used
in situ hybridization to assay for the spread of the virus using
in situ hybridization for gag [(Wang et al., 2004) and see
Figure 5E], and for the ectopic (and endogenous) expression of
Wnt2b (Figure 5F). Wnt2b was broadly expressed throughout the
frontonasal mesenchyme, up to the metencephalon (Figure 5F).
It is possible that, as a growth factor,Wnt2b signals to cells further
from infected areas, increasing Wnt2b expression.
We evaluated how ectopic Wnt2b expression affected the
expression domains of other molecular markers in the facial
prominences analyzing consecutive sections. We focused on three
key regulators: Shh (Cordero et al., 2004; Marcucio et al., 2005;
Abzhanov et al., 2007), Pax6 (Goudreau et al., 2002), and Fgf8
(Schneider et al., 2001) because of their pivotal roles in facial
development. Forty-eight hours after RCAS:Wnt2b delivery, the
Shh expression domains in the ventral portions of the telen-
cephalon, diencephalon and metencephalon, as well as in the
facial midline, were equivalent between control and RCAS:Wnt2b
treated embryos (Figures 5G,H).
Shh represses Pax6 expression (Macdonald et al., 1995),
and as expected, the pattern of Pax6 expression was precisely
opposite of the Shh expression domains: Pax6 transcripts were
detected in the dorsal regions of the telencephalon and meten-
cephalon and in the Rathke’s pouch (Figures 5I,J). As we had
observed with the Shh analyzes, Pax6 expression domains were
also unchanged by RCAS:Wnt2b treatment (Figures 5I,J). Fgf8
expression domains in the diencephalon and the frontonasal ecto-
derm were also similar between control and RCAS:Wnt2b treated
embryos (Figures 5K,L).
In sharp contrast, Msx1 expression domains were altered by
RCAS:Wnt2b. Endogenous Msx1 was expressed in the ectoderm
and surroundingmesenchyme of the anterior portion of the fron-
tonasal prominence as well as in the mandibular prominence
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FIGURE 5 | Wnt2b over-expression leads to ectopicMsx1 in the facial
prominences. (A) In situ hybridization for Msx1 in the avian facial
prominences at stage 17 HH. (B) In situ hybridization for Msx1 in the avian
facial prominences at stage 25 HH. Dashed lines delimit the lack of Msx1
expression in the midline of frontonasal prominence. (C,D) Mid-sagittal
section through the head of an uninjected embryo. (D) Endogenous Wnt2b
expression in the same embryo. (E) Mid-sagittal section through the head of
an embryo, analysed 24h after RCAS:Wnt2b infection, showing viral delivery
to the face. (F) RCAS:Wnt2b infection drives ectopic Wnt2b expression.
Forty-eight hours after RCAS:Wnt2b treatment, chicken embryos were
assessed for alterations in (G,H), Shh, (I,J) Pax6, (K,L) Fgf8 and (M,N)
Msx1expression.White arrows indicate expanded Msx1 expression domain.
Di, diencephalon; fn, frontonasal prominence; ln, lateral nasal prominence;
m, medial nasal prominence; mb, midbrain; me, metencephalon; mn,
mandibular prominence; mx, maxillary prominence; np, nasal pit; te,
telencephalon.
(Figure 5M). In RCAS:Wnt2b treated embryos, the Msx1 expres-
sion domain was expanded dorsally, in both the facial ectoderm
and mesenchyme, as well as in Rathke’s pouch at the 48-h time
point (Figure 5N). This ectopic Msx1 domain (Figure 5N) was
in the same general vicinity as the ectopic expression of Wnt2b
(Figure 5F).
These data showed that over-expression ofWnt2b did not affect
the domains of Shh, Pax6 or Fgf8. Ectopic Wnt activation in the
face, however, altered the expression of Msx1. Thus, we conclude
that Wnt signals regulate Msx1 expression in the embryonic face.
Wnt SIGNALING AND Msx1 REGULATE DEVELOPMENT OF THE
MAXILLARY PROMINENCES
In the developing chick, Wnt signaling regulates Msx1 expres-
sion in the facial prominences. To confirm this regulatory role,
we isolated mouse embryonic fibroblasts from E11.5 embryos
and exposed the cells to a Wnt stimulus for 4 h. Quantitative
RT-PCR for Msx1 and Gapdh demonstrated that Wnt3a signifi-
cantly enhanced expression of Msx1 (Figure 6A). Cells were also
treated with Wnt5a, which has recently been shown to activate
both beta catenin-dependent and independentWnt signaling (van
Amerongen et al., 2012), and again we found thatMsx1 expression
was significantly increased (Figure 6A). Collectively, these molec-
ular analyses verify thatWntstimuli candirectlyactivateMsx1gene
transcription.
We returned to evaluated the RCAS-Wnt2b treated embryos
and evaluated their facial phenotypes. Based on their analogous
expression domains in mouse (Figure 6B) and chick embryos
(Figure 6C), we were surprised to find that ectopic expression of
Msx1 in chicks produced a clefting phenotype, very similar to the
phenotype resulting from loss of Msx1 in mice. For example, loss
of Msx1 leads to a foreshortened maxilla in early mouse embryos
(Figures 6D,E) and in chick embryos, ectopicMsx1 expression led
to a similar foreshortened rostrum/upper beak (Figures 6F,G). In
mouse embryos, the foreshortened rostrum leads to a clefting
phenotype (compare Figure 6H with 6I). Birds have a natu-
rally occurring “cleft” between the palatal shelves, but in chick
embryos over-expressing Msx1 the palatal shelves were separated
by a much larger distance (compare Figure 6J with 6K). These
data indicate that disturbances in the balance of Msx1 expression
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FIGURE 6 | Loss and gain of Msx1 expression leads to a similar
clefting phenotype. (A) Msx1 gene expression induced by Wnt3a or
Wnt5a treatment in E11.5 MEFs. (B) Comparison between in situ
hybridization of Msx1 in mice and (C) chick embryos. (D) Lateral view of
E15.5 Msx1+/− and (E) Msx1−/− embryos. Bracket indicates the length of
the rostrum. (F) Lateral view of control and (G) RCAS-Wnt2b treated E8.5
chicken embryos. Bracket indicates the length of the upper beak. (H)
Ventral view of E15.5 Msx1+/− and (I) Msx1−/− embryos. Primary (1) and
secondary (2) palates are fused in Msx1+/− embryos but the secondary
palate is cleft in Msx1−/− embryos (arrows). (J) Ventral view of control
and (K) RCAS:Wnt2b treated E8.5 chicken embryos. Primary (1) palate is
fused while secondary (2) palate is naturally cleft in control embryos; note
widening of secondary palate secondary to ectopic Msx1 expression
(arrows). fn, frontonasal prominence; ln, lateral nasal prominence; m,
medial nasal prominence; mn, mandibular prominence; mx, maxillary
prominence.
interrupt maxillary prominence outgrowth, which contributes to
palatal clefts.
DISCUSSION
LOSS OF Msx1 REGULATES GROWTH OF THE MAXILLARY
PROMINENCES
Though its interactions with a core transcription complex and
other homeobox containing genes,Msx1 functions as a transcrip-
tional repressor (Alappat et al., 2003). In the developing face,
its primary site of activity is in the growing edges of the lateral
nasal, median nasal and maxillary prominences (Figures 3, 6). At
later stages of development, Msx1 is restricted to the anterior part
of the palatal shelves (Zhang et al., 2002; Hilliard et al., 2005)
and Msx1−/− embryos show complete secondary cleft palate
(Satokata and Maas, 1994).
The cleft palate phenotype has been attributed to cell prolif-
eration defects in the anterior region of the developing palatal
shelves at E13.5 (Hu et al., 2001; Zhang et al., 2002; Levi et al.,
2006) but our analyses demonstrate that loss of Msx1 disturbs
facial developmental events as early as E12.5 (Figures 1, 2). The
Msx1 gene expression domains at E11.5 and E12.5, together
with anatomical analyses, pinpoint that the maxillary prominence
is one of the primary facial structure affected by ablation of
Msx1. These data demonstrate that the Msx1−/− palatal pheno-
type develops as a compounded phenomenon to a disruption
in the outgrowth of the maxillary prominences. In other facial
regions Msx1 controls cell proliferation (Zhang et al., 2002; Han
et al., 2003), angiogenesis (Lopes et al., 2011) and tissue pat-
terning (Coudert et al., 2005; Ishii et al., 2005). We find that
angiogenesis is disrupted in the Msx1−/− maxillary prominences
(Figure 4).
Wnt/β-CATENIN SIGNALING AND Msx1 COOPERATIVE CONTROL
OF THE FACIAL DEVELOPMENT
Msx genes are downstream effectors of the Bmp pathway
(Marazzi et al., 1997; Bei and Maas, 1998; Tucker et al., 1998;
Hollnagel et al., 1999). Msx transcription factors also act as effec-
tors of Wnt and Fgf pathways (Chen et al., 1996; Willert et al.,
2002; Hussein et al., 2003). Despite the complex gene regula-
tory networks that exist among these signaling pathways we were
surprised to find that the interaction between Msx1 and Wnt/β-
catenin signaling in the developing face is remarkably specific.
The over-expression of Wnt2b, which exacerbates the normal
palatal clefting in chick embryos, did not perturb the expression
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domains of three key regulators of craniofacial development: Shh,
Pax6, and Fgf8.
There is undeniably a complex feedback regulation loop
between Wnt/β-catenin signaling and Msx1. While our data
demonstrate that Msx1 is a direct downstream target of Wnt/β-
catenin signaling during craniofacial development [Figures 5, 6A
and see (Song et al., 2009; Jin et al., 2011)] there is also data
demonstrating that Msx1 regulates expression and activity of the
Wnt/β-catenin pathway (Bach et al., 2003; Monsoro-Burq et al.,
2005; Revet et al., 2010; Nallasamy et al., 2012). Clearly, a better
understanding of this feedback loop will help unravel the initiat-
ing events that lead to CP. During later growth (Coudert et al.,
2005), the bidirectional transcription of Msx1 homeobox gene
would additionally intervene by finely controlling cell protein
levels (Petit et al., 2009).
PALATAL CLEFTING RESULTS FROM AN IMBALANCE IN Msx1
ACTIVITY
Teratologists and geneticists recognize that both excesses and defi-
ciencies in proteins can lead to similar phenotypes. For example,
mutations that causes abrogation of the Fgf receptor 2 (Fgfr2)
cause hypertelorism, craniosynostosis, and mid-facial hypopla-
sia (Hajihosseini et al., 2001; Eswarakumar et al., 2002). Gain of
function mutations that lead to constitutively active Fgfr2 cause
very similar phenotypes (Chen et al., 2003; Eswarakumar et al.,
2004; Wang et al., 2005; Yin et al., 2008; Holmes et al., 2009).
Likewise, a reduction in (Helms et al., 1996) or an excess of
(Schneider et al., 1999) retinoic acid cause very similar trunca-
tions in facial outgrowth.
By using both loss- and gain-of-function approaches in two
different species we demonstrated the conserved role of Msx1 in
regulating outgrowth of the maxillary prominences. We showed
that the lack and ectopic expression of the same protein caused
equivalent phenotypes in embryo facial development: shortened
rostrum/ upper beak, and cleft palate. These data strongly suggest
that there exist precise molecularmechanisms regulating the tran-
scriptional repressor activity of Msx1 during embryogenesis since
disturbance of this balance in either direction leads to maxillary
growth disturbances.
In conclusion, we show that E12.5 is a critical stage in facial
development for Msx1 function, and that imbalances in Wnt
signaling and Msx1 activity lead to failures in craniofacial devel-
opment that ultimately manifest as cleft palate.
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